login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VectivBio Holding AG (VECT) Stock News
USA
- NASDAQ:VECT -
CH1109007893
-
Common Stock
16.85
USD
0 (0%)
Last: 7/7/2023, 8:07:59 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VECT Latest News, Press Relases and Analysis
All
Press Releases
a year ago - By: NewAmsterdam Pharma N.V.
- Mentions:
NAMS
APGE
SYRE
ENGN
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
2 years ago - By: Ironwood Pharmaceuticals, Inc.
- Mentions:
IRWD
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
2 years ago - By: VectivBio AG
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
2 years ago - By: Benzinga
What 4 Analyst Ratings Have To Say About VectivBio Holding
2 years ago - By: The Motley Fool
- Mentions:
IRWD
Why Shares of VectivBio Holding Are Up Today
3 years ago - By: Benzinga
Piper Sandler Maintains Overweight Rating for VectivBio Holding: Here's What You Need To Know
2 years ago - By: VectivBio AG
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
2 years ago - By: Ironwood Pharmaceuticals, Inc.
- Mentions:
IRWD
Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio
2 years ago - By: The Motley Fool
- Mentions:
IRWD
Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround
2 years ago - By: Kahn Swick & Foti, LLC
VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT
2 years ago - By: Investor's Business Daily
- Mentions:
HZNP
AMGN
PFE
MRK
...
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
2 years ago - By: Kahn Swick & Foti, LLC
VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT
2 years ago - By: Investor's Business Daily
- Mentions:
IRWD
ABBV
VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion
2 years ago - By: Halper Sadeh LLC
VECT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of VectivBio Holding AG Is Fair to Shareholders
2 years ago - By: Seeking Alpha
- Mentions:
IRWD
Ironwood stock falls on deal to buy VectivBio for $1B (NASDAQ:IRWD)
2 years ago - By: VectivBio AG
VectivBio Publishes Invitation to the Annual General Meeting
3 years ago - By: VectivBio AG
VectivBio Reports Full Year 2022 Financial Results and Provides Business Update
3 years ago - By: Seeking Alpha
VectivBio files for $350M mixed shelf offering (NASDAQ:VECT)
3 years ago - By: Seeking Alpha
VectivBio initiated at buy at Jefferies on promise for intestinal disease candidate
Please enable JavaScript to continue using this application.